Callahan Takes Helm as CEO of MRIoA

Company - People | Feb 10, 2025 | Parthenon Capital LLC

Medical Review Institute of America (MRIoA) has appointed Megan Callahan as Chief Executive Officer. Supported by private equity firm Parthenon Capital, MRIoA is a provider of outsourced utilization management and clinical review solutions. Callahan, a seasoned executive with over 25 years of experience in healthcare technology, succeeds Ron Sullivan who retired at the end of January. Callahan's experience spans strategic roles at organizations like Lyft Healthcare and McKesson Technology Solutions. At MRIoA, she aims to lead further growth, supported by Parthenon Capital’s strategic focus on healthcare technology and outsourced solutions.

Sectors

  • Healthcare Technology
  • Private Equity
  • Outsourced Healthcare Solutions

Geography

  • United States – MRIoA is a leading clinical review company based in the United States.

Industry

  • Healthcare Technology – The article focuses on MRIoA, a company providing clinical review solutions enabled by technology.
  • Private Equity – Parthenon Capital, a private equity firm, supports MRIoA, indicating the involvement of private equity in healthcare technology.
  • Outsourced Healthcare Solutions – MRIoA provides outsourced utilization management, an integral part of healthcare outsourcing services.

Financials

    Participants

    NameRoleTypeDescription
    Megan CallahanChief Executive OfficerPeopleAppointed CEO of MRIoA, bringing 25 years of experience in healthcare technology.
    Ron SullivanFormer Chief Executive OfficerPeopleRetired CEO of MRIoA, having led the company since 2018.
    Dan KilleenPartnerPeoplePartner at Parthenon Capital, involved in strategic decisions for MRIoA.
    Medical Review Institute of America (MRIoA)CompanyCompaniesProvider of utilization management and clinical review solutions in healthcare.
    Parthenon CapitalPrivate Equity FirmCompaniesSupports MRIoA as a growth-oriented PE firm.